Kinetic and thermodynamic approaches to the drug targeting phenomena

Igor Meerovich1, Alexander Koshkaryev, Vladimir P Torchilin

  • 1Department of Pharmaceutical Sciences, Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston, MA 02115, USA.

Insights

Developing effective drug delivery systems requires carriers that reach specific sites, bind targets, and maintain therapeutic concentrations. This review analyzes targeting factors to improve drug delivery strategies for enhanced treatment efficacy.

Area of Science:

  • Biomedical Engineering
  • Pharmacology
  • Nanotechnology

Background:

  • Effective drug delivery is crucial for many therapies, especially anticancer agents, but requires specialized drug carriers.
  • Current drug carriers must reach target sites, bind effectively, and maintain therapeutic levels before organism clearance.
  • Existing targeting strategies involve active targeting substances (e.g., antibodies) and exploiting tumor microenvironment characteristics (e.g., pH, hypoxia).

Purpose of the Study:

  • To analyze the key factors influencing the targeting efficiency of drug delivery systems.
  • To provide a basis for developing improved drug delivery strategies by examining kinetic and thermodynamic principles.
  • To enhance the specificity and efficacy of drug carriers for therapeutic applications.

Main Methods:

  • Review of existing literature on drug delivery systems and targeting mechanisms.
  • Analysis of targeting strategies, including active targeting ligands and passive targeting based on tumor microenvironment.
  • Examination of kinetic and thermodynamic principles governing drug-vehicle interactions and biodistribution.

Main Results:

  • Targeting efficiency is influenced by factors such as ligand-receptor interactions, drug vehicle stability, and clearance rates.
  • Tumor microenvironment characteristics (pH, hypoxia) offer passive targeting opportunities.
  • Understanding kinetic and thermodynamic parameters is essential for optimizing drug delivery system design.

Conclusions:

  • Improved drug delivery systems necessitate a comprehensive understanding of targeting mechanisms.
  • Kinetic and thermodynamic analyses can guide the rational design of more effective drug carriers.
  • Future strategies should focus on optimizing targeting to enhance therapeutic outcomes and minimize off-target effects.

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Pharmacodynamics: Overview and Principles01:21

Pharmacodynamics: Overview and Principles

Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or within...
Pharmacokinetic–Pharmacodynamic Relationship: Problems01:24

Pharmacokinetic–Pharmacodynamic Relationship: Problems

The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...